Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
X4 Pharmaceuticals Announces EMA Validation of Marketing Authorization Application (MAA) for Mavorixafor - licenced to Norgine for commercialisation in Europe. 2025-01-25 02:00
Kelun-Biotech's Product Tagitanlimab Approved for Marketing in Second Indication in Combination with Cisplatin and Gemcitabine For the First-line Treatment of Patients with recurrent or metastatic NPC 2025-01-23 13:44
GC Cell Symposium with Bifarma Expands Global Impact and Reach for Immuncell-LC 2025-01-23 09:30
TraceLink Named to the 2025 RXinsider Pharmacy500 List for Excellence in Pharmacy Supply Chain Innovation 2025-01-22 23:00
JelloX Aims to Improve Patient-Centered Care with AI-powered 3D Digital Pathology 2025-01-22 15:29
Lepu Biopharma has granted ArriVent Exclusive License for MRG007, a Potential Best-in-Class ADC for the treatment of Gastrointestinal Cancers 2025-01-22 12:19
Ascletis Announces Positive Results from U.S. Phase Ia Single Ascending Dose Study of Small Molecule Oral GLP-1R Agonist ASC30 and Provides Program Update 2025-01-21 19:00
MedAdvisor Solutions' helps pharmacists in Australia deliver more than 115,000 clinical services to patients through Expanded Scope of Practice Pilots in 2024 2025-01-21 07:22
SIRPAD - WORLD'S LARGEST RCT INVESTIGATING MAGICTOUCH PTA SIROLIMUS COATED BALLOON COMPLETES PATIENT ENROLMENT 2025-01-20 21:44
Innovent and ASK Pharm Jointly Announce NMPA Approval of Limertinib, a Third-generation EGFR TKI for the Treatment of Lung Cancer 2025-01-17 08:00
Innovent Presents at the 43rd Annual J.P. Morgan Healthcare Conference 2025-01-17 07:00
Illuccix® Receives European Approval 2025-01-17 06:14
Concept Medical Announces First Patient Enrollment in the MAGICAL BTK IDE Trial, Launching its PAD Clinical Program in the United States 2025-01-17 03:15
SEACare 2025 - Your Gateway to Southeast Asia's Thriving Healthcare Market and Strategic Connections 2025-01-16 19:56
BGI Genomics Empowers Brunei's National Cervical Cancer Prevention Program 2025-01-16 12:51
Innovent Receives NMPA Breakthrough Therapy Designation for IBI343 (Anti-CLDN18.2 ADC) as Monotherapy for Advanced Pancreatic Cancer 2025-01-16 08:03
Samsung Biologics presents business updates at 2025 J.P. Morgan Healthcare Conference 2025-01-15 09:40
Axcynsis Therapeutics Receives FDA Clearance for IND Application of AT03-65, a Differentiated CLDN6-Targeting ADC, Powered by AxcynDOT™ Technology 2025-01-15 09:00
Telix Presentation to the 43rd Annual J.P. Morgan Healthcare Conference 2025-01-14 05:43
BioCina and NovaCina Merger Bolsters Global CDMO Industry 2025-01-14 00:43
1 2 3 4 5 253